AGC Biologics Cleared for Commercial Manufacture of Portola’s FDA-Approved Andexxa®
-Drug Substance produced in AGC Biologics’ facility in Bothell, Washington BOTHELL, Washington, May 24, 2018 /PRNewswire/ — AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins,…